12/04/2019 - 11:26

MGC secures permit to import epilepsy drug into the UK

12/04/2019 - 11:26

Bookmark

Save articles for future reference.

MGC Pharmaceuticals has received the green light to import its medicinal cannabis-based epilepsy drug CannEpil into the UK after it was awarded a controlled drug import licence permit. The permit allows the company to immediately expand distribution of CannEpil into the UK medicinal cannabis products market. It is also finalising negotiations with licensed distributors in the UK and Australia.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options